Marker Therapeutics Inc (MRKR)

[Investor_cmz]

With all the research coming out about t-cell immunity to coronavirus, I can’t help but wonder if maybe Polystart may become part of the conversation... thoughts?

Polystart

“This proprietary technology was invented by TapImmune Inc. and is fully owned by Marker Therapeutics and has applications in immuno-oncology as well as other areas like infectious disease. It can be applied to the company’s current T cell vaccine candidates, as well as drive incremental value for Marker through strategic out-licensing and/or collaboration with other companies.”